Report Detail
Global Drugs for Melanoma Market Research Report 2019
- RnM3144409 |
- 19 March, 2019 |
- Global |
- 93 Pages |
- QYResearch |
- Pharma & Healthcare
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the skin and is most common because most pigment cells are found in the skin. Mucosal melanoma is melanoma of mucous membrane of the body, including the mouth, the nasal passages, the throat, the vagina or the anus. The rare ocular melanoma or uveal melanoma occurs in the eye.
The global Drugs for Melanoma market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drugs for Melanoma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Melanoma market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Amgen
Bristol-Myers Squibb
Roche
Genentech
Janssen Biotech
Novartis
Pfizer
Sanofi
Takeda Pharma
Teva Pharma
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Segment by Application
Hospitals
Clinics
Others
Table of Contents
Executive Summary
1 Drugs for Melanoma Market Overview
- 1.1 Product Overview and Scope of Drugs for Melanoma
- 1.2 Drugs for Melanoma Segment by Type
- 1.2.1 Global Drugs for Melanoma Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Chemotherapy
- 1.2.3 Immunotherapy
- 1.2.4 Targeted Therapy
- 1.3 Drugs for Melanoma Segment by Application
- 1.3.1 Drugs for Melanoma Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Others
- 1.4 Global Drugs for Melanoma Market by Region
- 1.4.1 Global Drugs for Melanoma Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Drugs for Melanoma Market Size
- 1.5.1 Global Drugs for Melanoma Revenue (2014-2025)
- 1.5.2 Global Drugs for Melanoma Production (2014-2025)
2 Global Drugs for Melanoma Market Competition by Manufacturers
- 2.1 Global Drugs for Melanoma Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Drugs for Melanoma Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Drugs for Melanoma Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Drugs for Melanoma Production Sites, Area Served, Product Types
- 2.5 Drugs for Melanoma Market Competitive Situation and Trends
- 2.5.1 Drugs for Melanoma Market Concentration Rate
- 2.5.2 Drugs for Melanoma Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Drugs for Melanoma Production Market Share by Regions
- 3.1 Global Drugs for Melanoma Production Market Share by Regions
- 3.2 Global Drugs for Melanoma Revenue Market Share by Regions (2014-2019)
- 3.3 Global Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Drugs for Melanoma Production
- 3.4.1 North America Drugs for Melanoma Production Growth Rate (2014-2019)
- 3.4.2 North America Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Drugs for Melanoma Production
- 3.5.1 Europe Drugs for Melanoma Production Growth Rate (2014-2019)
- 3.5.2 Europe Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Drugs for Melanoma Production (2014-2019)
- 3.6.1 China Drugs for Melanoma Production Growth Rate (2014-2019)
- 3.6.2 China Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Drugs for Melanoma Production (2014-2019)
- 3.7.1 Japan Drugs for Melanoma Production Growth Rate (2014-2019)
- 3.7.2 Japan Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Drugs for Melanoma Consumption by Regions
- 4.1 Global Drugs for Melanoma Consumption by Regions
- 4.2 North America Drugs for Melanoma Consumption (2014-2019)
- 4.3 Europe Drugs for Melanoma Consumption (2014-2019)
- 4.4 China Drugs for Melanoma Consumption (2014-2019)
- 4.5 Japan Drugs for Melanoma Consumption (2014-2019)
5 Global Drugs for Melanoma Production, Revenue, Price Trend by Type
- 5.1 Global Drugs for Melanoma Production Market Share by Type (2014-2019)
- 5.2 Global Drugs for Melanoma Revenue Market Share by Type (2014-2019)
- 5.3 Global Drugs for Melanoma Price by Type (2014-2019)
- 5.4 Global Drugs for Melanoma Production Growth by Type (2014-2019)
6 Global Drugs for Melanoma Market Analysis by Applications
- 6.1 Global Drugs for Melanoma Consumption Market Share by Application (2014-2019)
- 6.2 Global Drugs for Melanoma Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Drugs for Melanoma Business
- 7.1 Amgen
- 7.1.1 Amgen Drugs for Melanoma Production Sites and Area Served
- 7.1.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.1.3 Amgen Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Bristol-Myers Squibb
- 7.2.1 Bristol-Myers Squibb Drugs for Melanoma Production Sites and Area Served
- 7.2.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.2.3 Bristol-Myers Squibb Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Roche
- 7.3.1 Roche Drugs for Melanoma Production Sites and Area Served
- 7.3.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.3.3 Roche Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Genentech
- 7.4.1 Genentech Drugs for Melanoma Production Sites and Area Served
- 7.4.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.4.3 Genentech Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Janssen Biotech
- 7.5.1 Janssen Biotech Drugs for Melanoma Production Sites and Area Served
- 7.5.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.5.3 Janssen Biotech Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Novartis
- 7.6.1 Novartis Drugs for Melanoma Production Sites and Area Served
- 7.6.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.6.3 Novartis Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Pfizer
- 7.7.1 Pfizer Drugs for Melanoma Production Sites and Area Served
- 7.7.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.7.3 Pfizer Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Sanofi
- 7.8.1 Sanofi Drugs for Melanoma Production Sites and Area Served
- 7.8.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.8.3 Sanofi Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Takeda Pharma
- 7.9.1 Takeda Pharma Drugs for Melanoma Production Sites and Area Served
- 7.9.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.9.3 Takeda Pharma Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Teva Pharma
- 7.10.1 Teva Pharma Drugs for Melanoma Production Sites and Area Served
- 7.10.2 Drugs for Melanoma Product Introduction, Application and Specification
- 7.10.3 Teva Pharma Drugs for Melanoma Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
8 Drugs for Melanoma Manufacturing Cost Analysis
- 8.1 Drugs for Melanoma Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Drugs for Melanoma
- 8.4 Drugs for Melanoma Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Drugs for Melanoma Distributors List
- 9.3 Drugs for Melanoma Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Drugs for Melanoma Market Forecast
- 11.1 Global Drugs for Melanoma Production, Revenue Forecast
- 11.1.1 Global Drugs for Melanoma Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Drugs for Melanoma Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Drugs for Melanoma Price and Trend Forecast (2019-2025)
- 11.2 Global Drugs for Melanoma Production Forecast by Regions (2019-2025)
- 11.2.1 North America Drugs for Melanoma Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Drugs for Melanoma Production, Revenue Forecast (2019-2025)
- 11.2.3 China Drugs for Melanoma Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Drugs for Melanoma Production, Revenue Forecast (2019-2025)
- 11.3 Global Drugs for Melanoma Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Drugs for Melanoma Consumption Forecast (2019-2025)
- 11.3.2 Europe Drugs for Melanoma Consumption Forecast (2019-2025)
- 11.3.3 China Drugs for Melanoma Consumption Forecast (2019-2025)
- 11.3.4 Japan Drugs for Melanoma Consumption Forecast (2019-2025)
- 11.4 Global Drugs for Melanoma Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Drugs for Melanoma Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Drugs for Melanoma. Industry analysis & Market Report on Drugs for Melanoma is a syndicated market report, published as Global Drugs for Melanoma Market Research Report 2019. It is complete Research Study and Industry Analysis of Drugs for Melanoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
